Suppr超能文献

膳食补充剂:名称里有什么?瓶子里有什么?

Dietary supplements: What's in a name? What's in the bottle?

作者信息

Marcus Donald M

机构信息

Baylor College of Medicine, Houston, TX, 77030, USA.

出版信息

Drug Test Anal. 2016 Mar-Apr;8(3-4):410-2. doi: 10.1002/dta.1855. Epub 2015 Nov 2.

Abstract

The Dietary Supplement Health and Education Act of 1994 (DSHEA), which arbitrarily classified herbals and other medicinal products as dietary supplements, obscured fundamental differences between two classes of products. Authentic supplements to the diet, such as multivitamins or calcium, have nutritional value and are safe. Herbals are used worldwide as medicines, they do not supplement the diet, they may cause severe adverse events, and they should be regulated as medicines. DSHEA also prevented the Food and Drug Administration (FDA) from effectively regulating herbal supplements as medicines. One consequence of weak FDA regulatory oversight is the poor quality of herbals. FDA inspections of manufacturing facilities have revealed violations of good manufacturing practices in over half of facilities inspected, including unsanitary conditions and lack of product specifications. Moreover, many "all natural" herbals marketed for weight loss, enhancement of sexual health and improving sports performance are adulterated with prescription and over-the-counter medications that have caused adverse cardiovascular events. New procedures to authenticate the identity of plants used in herbals will neither detect adulteration by medications nor provide assurance of appropriate pharmacological activity or safety. Nonvitamin, nonmineral "supplements" should be regulated as medicines, but revision or repeal of DSHEA faces strong opposition in Congress. The marketing of botanical supplements is based on unfounded claims that they are safe and effective. Health professionals need to inform patients and the public that there is no reason to take herbal medicines whose composition and benefits are unknown, and whose risks are evident.

摘要

1994年的《膳食补充剂健康与教育法》(DSHEA)将草药及其他药品随意归类为膳食补充剂,模糊了这两类产品之间的根本差异。真正的膳食补充剂,如多种维生素或钙,具有营养价值且安全。草药在全球范围内用作药物,它们并非膳食补充剂,可能会导致严重不良事件,应作为药品进行监管。DSHEA还使美国食品药品监督管理局(FDA)无法有效地将草药补充剂作为药品进行监管。FDA监管不力的一个后果是草药质量不佳。FDA对生产设施的检查发现,超过半数被检查的设施存在违反良好生产规范的情况,包括卫生条件差和缺乏产品规格。此外,许多用于减肥、增强性健康和提高运动表现而销售的“纯天然”草药被掺入了处方药和非处方药,这些药物已引发心血管不良事件。用于鉴定草药中所用植物身份的新程序既无法检测出药物掺假,也无法保证适当的药理活性或安全性。非维生素、非矿物质的“补充剂”应作为药品进行监管,但修订或废除DSHEA在国会面临强烈反对。植物性补充剂的营销基于毫无根据的说法,即它们安全且有效。健康专业人员需要告知患者和公众,没有理由服用成分和益处不明且风险明显的草药。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验